SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the focus of significant investor optimism as the community rallies around strong growth in its launch backlog and recent high-profile defense contracts. Despite broader market volatility, discussions are dominated by excitement over the company's expanding space systems capabilities and anticipation of upcoming earnings.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense volatility as investors weigh a major strategic partnership and infrastructure deal with NVIDIA against broader market concerns and concerns over financial dilution. The community is sharply divided, with bulls pointing to the company's long-term pivot to AI data centers as a massive catalyst, while bears are expressing skepticism over recent earnings and questioning the tangible impact of the announced agreements.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is surging following strong Q1 earnings that beat revenue and EPS estimates, alongside raised full-year guidance and new enterprise AI engagements. The community is actively discussing a potential short squeeze due to significant short interest and a low float, with many bulls holding for further gains while skeptics advise caution.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum driven by an aggressive shift toward a multi-billion dollar oncology franchise, particularly through its personalized cancer vaccine partnership with Merck, and renewed optimism surrounding regulatory approvals for its combination flu and Covid vaccine. The community is actively debating the stock's transition from a pandemic play to a long-term biotech platform, with bullish sentiment focused on institutional accumulation and a potential short squeeze, while some skeptics remain focused on long-term safety narratives and broader industry headwinds.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing significant volatility and increased investor interest ahead of earnings, fueled by speculation regarding potential new partnerships and the expansion of its Matrix-M adjuvant technology. The community is actively debating the stock's future, highlighting its role as a biotech infrastructure play and potential short-squeeze candidate, while closely monitoring news on upcoming regulatory trials and potential deals.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing intense volatility as the stock hits new 52-week lows, fueling community debate over whether this represents institutional manipulation, concerns regarding brand competition, or a deep-value buying opportunity ahead of quarterly results. Investors are actively split between those aggressively accumulating shares at these levels and those fearing further downside, while awaiting clarity on the company's growth trajectory and margin sustainability.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense market activity as investors reprice its role in the AI supply chain, focusing on structural memory shortages and long-term data center demand. The community is actively debating the stock's valuation re-rating, with many bulls highlighting memory's transition from a cyclical commodity to a core AI bottleneck while others express caution over the rapid vertical move.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the center of intense trading volume and community speculation, fueled by strong recent performance and rumors of strategic expansion projects. Traders are actively debating the stock's valuation as long-term investors weigh the company's innovation pipeline against retail exuberance and a heavy focus on short-term call options.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing heightened social media chatter and volatility as traders speculate on a potential short squeeze, fueled by the company's aggressive share buyback program, significant short interest, and a pivot toward AI-integrated local commerce. Community sentiment is deeply polarized, with bulls viewing the stock as a prime turnaround play with tightening float, while bears express skepticism regarding the company's long-term business model and earnings performance.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community actively discusses its newly filed lawsuit against distribution partner NS Pharma, with bulls interpreting the aggressive legal move as a strategic step to secure full control and commercial autonomy before a potential FDA approval. Investors are closely monitoring the litigation's impact on launch timelines while maintaining high conviction in the drug's data, viewing any near-term volatility as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Matija Kraševec

StockTwits Web

Howard Lindzon

StockTwits For Android 

Dave Moran

Stocktwits

Stocktwits Polls

Runir

david wadley

adolf hitler

jrobb

Direxion Daily Semiconductor Bear 3X Shares

permabullshitter

Jan Hill

aka Daddy Bags, aka Bags Vila

Craig McC

Myself

Mark Archibald

Orin Atlanson

StockCar

Osito

Venge

Asteroid Davis

Michelle

SayZero

ohjustbecause817

Lubos Ulovec

@StocktwitsPolls &quot;give us free data to sell&quot;

Your Highness

AKABootzterDaBearBlocker2000

Erica Neiderer

JayRight

Tall Tex

InThaGreen

Mat Cuinu

alankr

Tariffs Suck

Bobo

Possibly Professional Trader

mathew reinhart

Bennito

Ranger Bob

@StocktwitsPolls If we all give wrong answers only will it throw MM off?

OptionTECH CEO

 If we all give wrong answers only will it throw MM off?

@StocktwitsPolls  
 
Why the hell would you be long here?

The Dude

Master Jedi

KEITH

dogg78294

Im_Trying

Dario Cummings

D King

Because it&#39;s more profitable than being short or neutral???

Evan

  
 
Why the hell would you be long here?

Ben Dover

@StocktwitsPolls looks like a lot of investors are max long. Max long buying into an ATH. High inflation, AI software struggling with ROI, big layoffs from tech to pay for overspending on AI that makes no real money, increasing US debt, and the list goes on.

NorthOfSouth

Igor Gab

Diogo

 looks like a lot of investors are max long. Max long buying into an ATH. High inflation, AI software struggling with ROI, big layoffs from tech to pay for overspending on AI that makes no real money, increasing US debt, and the list goes on.

How are you positioned right now?